Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Nephros (NEPH) over the last 16 years, with Q3 2025 value amounting to $516000.0.

  • Nephros' Change in Inventory rose 5636.36% to $516000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$257000.0, marking a year-over-year decrease of 12082.66%. This contributed to the annual value of $407000.0 for FY2024, which is 20516.8% up from last year.
  • As of Q3 2025, Nephros' Change in Inventory stood at $516000.0, which was up 5636.36% from $318000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Change in Inventory registered a high of $516000.0 during Q3 2025, and its lowest value of -$714000.0 during Q1 2023.
  • Its 5-year average for Change in Inventory is -$45368.4, with a median of $44000.0 in 2022.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 46307.69% in 2021, then tumbled by 96567.16% in 2023.
  • Quarter analysis of 5 years shows Nephros' Change in Inventory stood at $236000.0 in 2021, then crashed by 242.37% to -$336000.0 in 2022, then skyrocketed by 216.37% to $391000.0 in 2023, then plummeted by 211.51% to -$436000.0 in 2024, then surged by 218.35% to $516000.0 in 2025.
  • Its Change in Inventory stands at $516000.0 for Q3 2025, versus $318000.0 for Q2 2025 and -$655000.0 for Q1 2025.